α1-Acid Glycoprotein and Plasma Lidocaine Binding
- 1 January 1984
- journal article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 9 (Supplement) , 27-31
- https://doi.org/10.2165/00003088-198400091-00004
Abstract
The relationship between the degree of plasma binding of lidocaine (lignocaine) and the concentration of the acute phase reactant, α1-acid glycoprotein (AAG), is reviewed. Studies in normal subjects...Keywords
This publication has 29 references indexed in Scilit:
- PHARMACOKINETIC STUDIES: THEIR ROLE IN DETERMINING THERAPEUTIC EFFICACY OF AGENTS DESIGNED TO PREVENT SUDDEN DEATH*Annals of the New York Academy of Sciences, 1982
- The artifactual nature of heparin-induced drug protein-binding alterationsClinical Pharmacology & Therapeutics, 1981
- Changes in plasma drug binding and α1-acid glycoprotein in mother and newborn infantClinical Pharmacology & Therapeutics, 1981
- Increased Alpha-1-Acid Glycoprotein and Lidocaine Disposition in Myocardial InfarctionAnnals of Internal Medicine, 1980
- Administration of heparin causes release of non-esterified fatty acids in human plasmaLife Sciences, 1980
- Rapid Serum Lidocaine Determination in the Coronary Care UnitJAMA, 1980
- Importance of blood-collection tubes in plasma lidocaine determinations.Clinical Chemistry, 1979
- Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure.BMJ, 1976
- Spuriously low plasma propranolol concentrations resulting from blood collection methodsClinical Pharmacology & Therapeutics, 1975
- [Differentiated quantitative serum protein determination during myocardial infarct].1968